Roxadustat and the Interpretation of Non-Inferiority
freecme000
Published on Nov 29, 2022
CLICK ON LINK BELOW
https://www.asn-online.org/media/podcast/JASN/2022_04_11_JASN2021050681.mp3
Dr. Josie Briggs, discusses a non-inferiority trial on Roxadustat in dialysis patients and explains the interpretation of the finding that roxadustat is non-inferior to epoetin alpha.
Category
Tags
- Your Subscription
freecme000 -
Share Podcast
Add to
Please Sign In or Create Account to use this feature!
Flag Podcast
Please Sign In or Create Account to use this feature!
Rate podcast
Please Sign In or Create Account to use this feature!
Rate podcast
Please Sign In or Create Account to use this feature!
Up next
Autoplay
Autoplay
Recommended
-
00:04
Acute Interstitial Nephritis and Checkpoint Inhibitor Therapy
38 views 1173 days ago -
00:04
Venous Thrombotic Events in ANCA-Associated Vasculitis: Incidence and Risk Factors
37 views 1173 days ago -
00:04
Addressing CKD Progression and Hazards of Intradialytic Hypotension
46 views 878 days ago